Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/11/2026

1. NVDA
2. RKLB
3. SPY
4. SION
5. B
6. MNDY
7. CSQR
8. ACH
9. ACVA
10. INTC

Go back to Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
(NASDAQ: VERU) Delayed: 2.77 --0 (-0%)
Previous Close $2.77    52 Week High $ 
Open $2.77    52 Week Low $ 
Day High $2.77    P/E N/A 
Day Low $2.77    EPS $ 
Volume 915